Advanced Enzyme Technologies receives revised request for promoter reclassification

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Radhika Ashish Pujara requested reclassification from Promoter Group to Public category
  • The request was submitted on September 28, 2026, under Regulation 31A of SEBI LODR
  • Pujara holds NIL equity shares and exercises no control over the company
  • The reclassification is subject to Board and stock exchange approvals
powered bylight_fuzz_icon
52234396

*this image is generated using AI for illustrative purposes only.

Advanced Enzyme Technologies Ltd has received a revised request from Radhika Ashish Pujara, a member of its Promoter Group, seeking reclassification to the Public category. The request was submitted on September 28, 2026, and received by the company on September 29, 2026.

This development follows an earlier intimation dated September 5, 2026. The reclassification is sought under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that the request remains subject to approval by its Board of Directors and the stock exchanges.

Reclassification details

Radhika Ashish Pujara currently holds no equity shares in the company. Her shareholding percentage is also nil. The following table outlines her current status:

Name Category Shareholding (No. of Equity Shares) Percentage
Radhika Ashish Pujara Promoter Group NIL NIL

Declarations made

In her letter to the Board of Directors, Pujara confirmed that she does not hold any equity shares or voting rights in the company. She further declared that she does not exercise control over the affairs of the company, either directly or indirectly. Key points from her declaration include:

  • She is not involved in the management or day-to-day affairs of the company.
  • She holds no special rights through any formal or informal arrangement, including shareholder agreements.
  • She is not represented on the Board of Directors and is not a Key Managerial Personnel.
  • She is not acting as a promoter or holding herself out as one.
  • She is not acting in concert with existing Promoters or the Promoter Group.
  • There are no circumstances allowing her to exercise control or influence over the company's management.
  • She is not a wilful defaulter as per Reserve Bank of India guidelines nor a fugitive economic offender.

Pujara requested the Board to initiate the process for her reclassification and undertake all necessary corporate and regulatory actions, including applications to stock exchanges. The company signed the intimation via Sanjay Basantani, Company Secretary and Head-Legal.

Historical Stock Returns for Advanced Enzyme Tech

1 Day5 Days1 Month6 Months1 Year5 Years
-0.35%-4.05%-5.89%+6.11%-11.83%-26.68%

Will the Board of Directors and stock exchanges approve the reclassification request under Regulation 31A, and what is the expected timeline for this regulatory clearance?

How might the formal reclassification of Radhika Ashish Pujara to the Public category impact the overall promoter holding percentage and market perception of Advanced Enzyme Technologies Ltd?

Are there other members of the Promoter Group at Advanced Enzyme Technologies Ltd who may seek similar reclassification, potentially signaling a broader shift in the company's ownership structure?

Advanced Enzyme Tech buys 25,000 shares on Sep 29 at avg ₹283.60

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Advanced Enzyme Technologies bought back 25,000 shares on September 29, 2026
  • Average acquisition price was ₹283.60 per share on NSE
  • Cumulative shares bought back reached 16,88,324 as of Sep 29
  • No shares were closed out during the reporting period
powered bylight_fuzz_icon
48014513

*this image is generated using AI for illustrative purposes only.

Advanced Enzyme Technologies Limited repurchased 25,000 equity shares on September 29, 2026, continuing its open market buyback program. The average acquisition price for the day was ₹283.60.

Emkay Global Financial Services Limited, the Manager to the Buyback, facilitated these transactions exclusively on the National Stock Exchange (NSE). No transactions were reported on the Bombay Stock Exchange (BSE) or Mumbai Stock Exchange (MSEI). There were no closed-out quantities reported for the day.

Daily Buyback Report (Sep 29)

The daily report submitted to the stock exchanges confirms active acquisition for the day.

Metric Details
Shares Bought Back (Sep 29) 25,000
Average Acquisition Price ₹283.60
Exchange NSE
Broker Emkay Global Financial Services Limited
Cumulative Shares Bought Back 16,88,324

Buyback Progress Update

As of September 29, 2026, the cumulative number of equity shares bought back stood at 16,88,324. This is an increase from the previous cumulative total of 16,63,324 shares reported as of September 28, 2026. This progress moves the company closer to its initial deployment target of ₹278,800,000, which must be utilized within the first half of the offer period. The total quantity closed out remains at zero.

Buyback Offer Parameters

The buyback targets up to 1,394,000 equity shares, constituting approximately 1.24% of the total paid-up equity share capital as of August 8, 2026. The maximum buyback size is ₹697,000,000, funded entirely from free reserves and internal accruals with no borrowed funds utilized.

Parameter Details
Maximum Buyback Size ₹697,000,000
Maximum Buyback Price ₹500 per Equity Share
Maximum Buyback Shares 1,394,000
Minimum Buyback Size (75%) ₹522,750,000
Initial Deployment (40%) ₹278,800,000
Face Value ₹2/- each
Method Open market through stock exchanges
Source of Funds Free reserves and internal accruals

The company is required to utilize at least 75% of the Maximum Buyback Size, i.e., ₹522,750,000. Furthermore, at least 40% of the Buyback Size, i.e., ₹278,800,000, must be deployed within the initial half of the Offer Period. The buyback offer is expected to open on or before August 14, 2026, and close no later than November 20, 2026, being sixty-six Working Days from the opening date.

Premium and Market Context

The Maximum Buyback Price of ₹500 carries a substantial premium over recent market benchmarks. On August 8, 2026, the closing market price was ₹324.40 on BSE and ₹324.35 on NSE. The acquisition price of ₹283.60 on September 29 remains well below the maximum ceiling.

Benchmark Period Premium on BSE Premium on NSE
3-month VWAP (prior to Aug 1, 2026) 42.42% 42.43%
2-week VWAP (prior to Aug 1, 2026) 58.95% 58.88%
1-month VWAP (prior to Aug 1, 2026) 56.62% 56.63%
Closing price (Aug 1, 2026) 58.73% 58.68%

This premium reflects management’s confidence in the intrinsic value of the shares and serves as a strong signal to investors regarding the company’s financial health and future prospects.

Capital Structure Impact

If the full Maximum Buyback Size is utilized at the Maximum Buyback Price, the issued, subscribed, and paid-up capital will reduce from 111,976,150 shares to 110,582,150 shares. Promoters and persons in control are excluded from participating in the buyback; their shares will remain frozen at the ISIN level from August 8, 2026, until the buyback closes.

Category Pre Buyback Shares Pre Buyback % Post Buyback Shares Post Buyback %
Promoter and Promoter Group 48,419,510 43.24 48,419,510 43.79
Public Shareholders 63,556,640 56.76 62,162,640 56.21
Total 111,976,150 100.00 110,582,150 100.00

Financial Health and Rationale

The buyback is underpinned by strong financial performance. For Q1 FY27 (ended June 30, 2026), the company reported Revenue from Operations of ₹1,158.57 million and Profit After Tax of ₹223.46 million. In FY26, Revenue from Operations stood at ₹4,527.66 million with a PAT of ₹1,318.06 million.

The Board confirmed that the company has no subsisting defaults in repayment of deposits, debentures, preference shares, dividends, or term loans. A cash escrow of ₹174,250,000 (25% of Maximum Buyback Size) has been deposited with HDFC Bank Limited. Emkay Global Financial Services Limited serves as the Manager to the Buyback, while MUFG Intime India Private Limited is the Registrar. The process complies with Regulation 5(vii) of the SEBI (Buy-back of Securities) Regulations, 2018, and relevant provisions of the Companies Act, 2013.

Historical Stock Returns for Advanced Enzyme Tech

1 Day5 Days1 Month6 Months1 Year5 Years
-0.35%-4.05%-5.89%+6.11%-11.83%-26.68%

How will the remaining buyback window until November 20 impact the pace of share acquisition given the current cumulative progress?

What are the potential implications for Advanced Enzyme's EPS and ROE once the full 1.24% reduction in share capital is realized?

How might the significant premium of the ₹500 buyback price over recent market levels influence institutional investor sentiment toward the stock?

More News on Advanced Enzyme Tech

1 Year Returns:-11.83%